Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
Explore this paper's citation graph
Summary
It is demonstrated that women with T1DM exhibit higher sclerostin levels than men and that circulating sclerOSTin is not associated with bone turnover markers and phalangeal QUS measurements.
- Type
- article
- Published
- 2014-09-01
- Cited by
- 42
- References
- 43
- Access
- Open access
- OpenAlex
- https://openalex.org/W2168117172
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43633282
Keywords
Sclerostin, Internal medicine, Endocrinology, Bone remodeling, Pyridinoline
References
- Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with Type 1 diabetes mellitus
- Sclerostin: Current Knowledge and Future Perspectives
- WNT and β-catenin signalling: diseases and therapies
- Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
- The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
- Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus
- Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids
- Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
- Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
- The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt–β-catenin signalling through Dishevelled
- Vascular Bmp–Msx2–Wnt Signaling and Oxidative Stress in Arterial Calcification
- Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study
- Poor Glycemic Control is Associated with Low BMD Detected in Premenopausal Women with Type 1 Diabetes
- Sclerostin: Another vascular calcification inhibitor?
- Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
- Standards of medical care in diabetes.
- THE RELATION BETWEEN OSTEOPOROSIS AND AORTIC CALCIFICATION.
- High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The center of excellence for osteoporosis research study
- Osteoporosis among patients with type 1 and type 2 diabetes.
- Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Cited by
- Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density
- Type 1 Diabetes and Osteoporosis: From Molecular Pathways to Bone Phenotype
- Diabetes and Bone: Still a Lot to Learn
- MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.
- Biochemical bone turnover markers in diabetes mellitus - A systematic review.
- Differences in biochemical bone markers by diabetes type and the impact of glucose.
- Sclerostin in Obstructive Sleep Apnea.
- Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition
- Association of Sclerostin with Bone Metabolism and Bone Mineral Density in Adults with Type 1 Diabetes Mellitus
- Low serum sclerostin levels in newborns with vitamin D deficiency
- Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors
- Investigations of Diabetic Bone Disease
- Effects of Type 1 Diabetes on osteoblasts, osteocytes and osteoclasts
- Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes.
- MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
- Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab
- Normal Bone Density and Trabecular Bone Score, but High Serum Sclerostin in Congenital Generalized Lipodystrophy
- Fracture Risk Assessment in Patients With Diabetes Mellitus.
- Multiple fractures and impaired bone metabolism in Wolfram syndrome: a case report.
- Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus
Related papers
- Seasonal differences in biochemical parameters of bone remodelling.
- Biochemical markers of bone turnover during hormone replacement therapy
- Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
- Vitamin d status and indices of bone turnover in older European adults.
- Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
- Biomarkers of Bone Remodeling in Children with Mucopolysaccharidosis Types I, II, and VI
- Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption
- Collagen cross-link excretion during space flight and bed rest.
- Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease.
- Bone turnover in untreated polymyalgia rheumatica.